Best Stocks to Buy in 2026: Top 10 Picks

Photo by Nataliya Vaitkevich on Pexels

The S&P 500 enters mid-2026 trading at roughly 22x trailing earnings and 20x forward earnings, with a headline yield near 1.4% and the 10-year Treasury parked around 4.0%. That leaves a thin equity risk premium and almost no margin for sloppy stock picking — which is why we put 500 large-caps through a four-factor screen this quarter and narrowed the list to ten names we believe still offer asymmetric upside over a three- to five-year window.

This guide is built for investors who already understand position sizing and time horizon. We are not chasing one-quarter momentum names; every pick had to clear thresholds for cash conversion, balance-sheet quality, and reinvestment runway. Where valuation is rich, we explain what the market is paying for. Where it looks cheap, we explain the embedded risk.

How We Ranked

We started with the Russell 1000 universe, removed companies with negative free cash flow over the trailing two years, and screened for ROIC above the cost of capital, net debt under 2x EBITDA, and a defensible margin trend. We then layered analyst revision data and modeled a discounted cash flow at a 9% discount rate. Final ranking weights: 30% valuation versus our DCF, 25% earnings durability, 20% balance sheet, 15% capital allocation, and 10% sector positioning for the 2026 rate and AI capex regime.

Rank	Ticker	Sector	Forward P/E	5-Yr EPS CAGR (Est.)	Dividend Yield
1	NVDA	Semiconductors	32x	24%	0.0%
2	MSFT	Software	30x	15%	0.7%
3	BRK.B	Conglomerate	21x	9%	0.0%
4	V	Payments	26x	12%	0.7%
5	LLY	Pharma	35x	18%	0.6%
6	COST	Retail	45x	10%	0.5%
7	AVGO	Semis/Software	28x	16%	1.5%
8	UNH	Healthcare	17x	11%	1.6%
9	JPM	Banking	12x	7%	2.4%
10	GOOGL	Internet	22x	13%	0.4%

Affiliate disclosure: Finace Stoks may earn a commission when you sign up through broker links in this article. This never affects our rankings — every stock is reviewed on the same scoring rubric.

1. NVIDIA (NVDA)

The data-center cycle has not broken. Hyperscaler capex guides for 2026 imply roughly $300B in combined infrastructure spend, and NVDA still captures the majority of accelerator dollars. Gross margins above 70% remain the tell.

Pros: CUDA moat, Blackwell ramp, >70% gross margin, expanding software ARR. Cons: Customer concentration, China export restrictions, cyclical capex risk. ➡️ Trade NVDA at Fidelity

2. Microsoft (MSFT)

Azure growth has stabilized in the high-20s and Copilot attach is finally translating to per-seat ARPU lift. We model 15% EPS CAGR with optionality from the OpenAI partnership.

Pros: Recurring revenue, AI distribution, $80B+ FCF, fortress balance sheet. Cons: Capex intensity rising, antitrust scrutiny, valuation premium. ➡️ Trade MSFT at Charles Schwab

3. Berkshire Hathaway (BRK.B)

Cash above $190B is a feature, not a bug, in a 4% Treasury world. We see the float earning more than at any point in the last 15 years.

Pros: Diversified cash flow, deep liquidity, disciplined capital allocation. Cons: Succession overhang, slower compounding at scale. ➡️ Trade BRK.B at Interactive Brokers

4. Visa (V)

Cross-border volumes recovered fully and value-added services now contribute over 25% of revenue. Operating margins above 65% are the cleanest in the index.

Pros: Network effect, pricing power, asset-light model. Cons: Regulatory risk, stablecoin disruption narrative. ➡️ Trade V at E*TRADE

5. Eli Lilly (LLY)

GLP-1 demand still exceeds supply, with manufacturing capacity coming online through 2027. The pipeline beyond Mounjaro/Zepbound is the under-modeled part.

Pros: Category leadership, pricing power, durable demand. Cons: Patent cliff risk, manufacturing execution, biosimilar pressure post-2030. ➡️ Trade LLY at Robinhood

6. Costco (COST)

A 45x multiple is uncomfortable, but membership fee growth and renewal rates above 90% justify a premium. Same-store sales remain mid-single-digits even at this scale.

Pros: Membership moat, inflation-resistant, e-commerce optionality. Cons: Valuation, low yield, limited geographic expansion runway. ➡️ Trade COST at Webull

7. Broadcom (AVGO)

The VMware integration is largely done and custom-silicon revenue with hyperscalers is the kicker. Combined ASIC plus networking exposure is the second-best AI play after NVDA.

Pros: Diversified end markets, FCF conversion, dividend growth. Cons: Integration debt, customer concentration in custom silicon. ➡️ Trade AVGO at Public

8. UnitedHealth (UNH)

Medical-loss-ratio pressure has compressed the multiple to 17x — its widest discount to the S&P in a decade. Optum’s vertical integration thesis is intact.

Pros: Scale advantages, Optum growth, attractive entry valuation. Cons: Regulatory headlines, MLR volatility, political risk. ➡️ Trade UNH at M1 Finance

9. JPMorgan Chase (JPM)

Net interest income is normalizing but credit costs remain benign. At 12x with a 2.4% yield and 15%+ ROTCE, JPM is the highest-quality bank trading at a sector multiple.

Pros: Best-in-class management, capital return, fortress balance sheet. Cons: Cyclical earnings, regulatory capital headwinds. ➡️ Trade JPM at SoFi Invest

10. Alphabet (GOOGL)

Search monetization concerns are overstated and YouTube + Cloud now contribute roughly 30% of revenue. AI capex is heavy, but FCF still exceeds $90B annually.

Pros: Cash generation, AI infrastructure, YouTube optionality. Cons: Antitrust remedies, search disruption narrative, capex visibility. ➡️ Trade GOOGL at Vanguard

Valuation Snapshot

Ticker	EV/EBITDA	FCF Yield	ROIC	Net Debt/EBITDA
NVDA	28x	2.6%	78%	Net cash
MSFT	22x	3.1%	28%	Net cash
BRK.B	n/m	4.0%	11%	Net cash
LLY	30x	1.8%	32%	0.6x
AVGO	21x	4.2%	19%	1.7x
JPM	n/m	11.5%	17%	n/m

How to Buy These Stocks

1. Open a taxable brokerage account or use available room in your IRA before deploying capital.
2. Decide on a position-sizing rule — we suggest no single name above 7% of your equity sleeve.
3. Build positions in thirds over three to six months to dampen entry timing risk.
4. Reinvest dividends automatically for compounders like V, AVGO, and JPM.
5. Re-screen quarterly; trim names that no longer pass the original four-factor test.

Recommended Offers

💡 Editor’s pick: Fidelity remains our default broker for long-term equity portfolios. $0 commissions, fractional shares, and best-in-class research make it our top recommendation for most readers.

💡 Editor’s pick: Interactive Brokers is the right choice if you want global market access, margin under 6%, and tools built for active rebalancing. The platform learning curve is real, but worth it.

💡 Editor’s pick: M1 Finance is our pick for set-and-forget portfolio building. The pie-based system enforces position sizing automatically — useful for keeping a 10-stock book disciplined.

FAQ — Best Stocks to Buy in 2026

Q: Are these picks suitable for beginners? A: Most are large-cap, liquid, and well-covered, which makes them appropriate for new investors who already hold a core index allocation. We recommend reading our beginner’s guide first.

Q: How much should I invest in any single stock? A: We cap individual positions at 7% of an equity portfolio. For higher-conviction names like MSFT or BRK.B, some investors stretch to 10%, but we don’t recommend more.

Q: What if the market sells off after I buy? A: Drawdowns are normal. Build positions in tranches, keep a cash reserve for adds, and avoid leverage on these positions.

Q: Should I prefer dividends or growth from this list? A: It depends on your tax bracket and income needs. Dividend names (JPM, AVGO, V) suit taxable accounts in lower brackets; growth names (NVDA, LLY) work better in IRAs.

Q: How often should I rebalance? A: Quarterly review, annual rebalance is sufficient for a long-term portfolio. Trim positions that drift above 10% of the portfolio.

Q: Are international stocks missing on purpose? A: This list is US-focused. We cover ADRs and international equities in separate guides linked below.

Related Reading on Finace Stoks

• How to Invest in the Stock Market: 2026 Beginner’s Guide
• Best Dividend Stocks of 2026
• Best Tech Stocks to Watch in 2026
• Best Blue-Chip Stocks for 2026
• Best ETFs of 2026

Final Verdict

Our top three picks — NVDA, MSFT, and BRK.B — pair durable cash generation with distinct macro exposures, which is what you want in a market trading near the high end of its post-2010 valuation range. If we had to build a five-stock starter portfolio from this list, we would weight equally across MSFT, BRK.B, V, JPM, and GOOGL, and add NVDA only on a 15% pullback from current levels.

This article is for informational purposes only and is not investment advice. Stock prices, dividends, and market data are accurate as of publication and subject to change. Investing involves risk including loss of principal. Finace Stoks may receive compensation for some placements; rankings are independent.